Rational Drug Design: Methods and Protocols

Book Overview

1. On Setting up and Assessing Docking Simulations for Virtual Screening

Jacek Biesiada, Aleksey Porollo, Jaroslaw Meller

2. Virtual Ligand Screening Combined with NMR to Identify Dvl PDZ Domain Inhibitors Targeting the Wnt Signaling

Jufang Shan and Jie J. Zheng

3. Rational Design of Rho GTPase Targeting Inhibitors

Xun Shang and Yi Zheng

4. Rational Design of Peptide Ligands Against a Glycolipid by NMR Studies

Wenyong Tong, Tara Sprules, Kalle Gehring, H. Uri Saragovi

5. A Combinatorial Strategy for the Acquisition of Potent and Specific Protein Tyrosine Phosphatase Inhibitors

Sheng Zhang, Lan Chen, David S. Lawrence and Zhong-Yin Zhang

6. Identification of Allosteric Inhibitors of p21-Activated Kinase

Julien Viaud and Jeffrey R. Peterson

7. Using a Modified Yeast Two-hybrid System to Screen for Chemical GEF InhibitorsAnne Blangy and Philippe Fort .

8. Random Mutagenesis of Peptide Aptamers As An Optimization Strategy for Inhibitor Screening

Nathalie Bouquier, Sylvie Fromont, Anne Debant and Susanne Schmidt

9. A Screening Strategy for Trapping the Inactive Conformer of a Dimeric Enzyme with a Small Molecule Inhibitor

Tina Shahian and Charles S. Craik

10. Use of a Fluorescent ATP Analog to Probe the Allosteric Conformational Change in the Active Site of the Protein Kinase PDK1

Valerie Hindie, Laura A. Lopez-Garcia, and Ricardo M. Biondi

11. Affinity Purification of Protein Kinases that Adopt a Specific Inactive ConformationPratistha Ranjitkar and Dustin J. Maly 12. Determination of the Kinetics and Thermodynamics of Ligand Binding to a Specific Inactive Conformation in Protein KinasesSanjay B. Hari, Pratistha Ranjitkar and Dustin J. Maly

13. Purification and Specific Assays for Measuring APE-1 Endonuclease Activity

Adrian Esqueda, Mohammed Z Mohammed, Srinivasan Madhusudan, and Nouri Neamati

14. An in vitro Screening to Identify Drug Resistant Mutations for Target-directed Chemotherapeutic Agents

Mohammad Azam

15. Utilizing AntagomiR (anti-sense microRNA) to Knock Down microRNA in Murine Bone Marrow Cells

Chinavenmeni S. Velu and H. Leighton Grimes

16. Synthesis, Conjugation, and Labeling of Multifunctional pRNA Nanoparticles for Specific Delivery of siRNA, Drugs and Other Therapeutics to Target Cells

Mathieu Cinier, Yi Shu, Daniel Binzel, and Peixuan Guo

17. Mouse Models for Tumor Metastasis

Shengyu Yang, J. Jillian Zhang, and Xin-Yun Huang

1. On Setting up and Assessing Docking simulations for Virtual Screening

Jacek Biesiada, Aleksey Porollo, Jaroslaw Meller

2. Virtual Ligand Screening Combined with NMR to Identify Dvl PDZ Domain Inhibitors Targeting the Wnt Signaling

Jufang Shan and Jie J. Zheng

3. Rational Design of Rho GTPase Targeting Inhibitors

Xun Shang and Yi Zheng

4. Rational Design of Peptide Ligands Against a Glycolipid by NMR Studies

Wenyong Tong, Tara Sprules, Kalle Gehring, H. Uri Saragovi

5. A Combinatorial Strategy for the Acquisition of Potent and Specific Protein Tyrosine Phosphatase Inhibitors

Sheng Zhang, Lan Chen, David S. Lawrence and Zhong-Yin Zhang

6. Identification of Allosteric Inhibitors of p21-Activated Kinase

Julien Viaud and Jeffrey R. Peterson

7. Using a Modified Yeast Two-hybrid System to Screen for Chemical GEF InhibitorsAnne Blangy and Philippe Fort .

8. Random Mutagenesis of Peptide Aptamers As An Optimization Strategy for Inhibitor Screening

Nathalie Bouquier, Sylvie Fromont, Anne Debant and Susanne Schmidt

9. A Screening Strategy for Trapping the Inactive Conformer of a Dimeric Enzyme with a Small Molecule Inhibitor

Tina Shahian and Charles S. Craik

10. Use of a Fluorescent ATP Analog t

• Format: Paperback
• Language: English
• ISBN: 149395900X
• ISBN13: 9781493959006
• Release Date: August 2016
• Publisher: Humana
• Length: 230 Pages
• Weight: 0.95 lbs.
• Dimensions: 0.5" x 7.0" x 10.0"